Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Feb 15, 2005 (Vol. 25, No. 4)

ESA EcoEdNet Homepage

URL:www.ecoed.net/
  • Large volume of info
  • Registration Required
What to do about global warming, habitat destruction, and the rapidly diminishing species diversity on Earth? Like every other problem facing us, the first step is to educate, and that is the approach taken by the excellent ESA EcoEdNet page. Information is organized at the site in eight broad categories: Biodiversity, Evolution, Ecology/Technology/ Policy, Ecology as Science, Energy Transfer, Continuity and Change, Regulation, and Interactions. Access to information at the site is restricted to registered users (free), which is rather unfortunate. I recognize that registration provides some control, and that registration information is valuable and thus can help pay the expenses of a site, but the information here would seem to be so important that free and easy access to all should be considered.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »